John W Weis

Title: The Innovations of John W. Weis

Introduction

John W. Weis is a notable inventor based in Minneapolis, MN (US). He has made significant contributions to the field of virology, particularly in the production of herpes simplex viral proteins. His work has implications for vaccine development, showcasing the intersection of biotechnology and public health.

Latest Patents

John W. Weis holds a patent for the "Production of herpes simplex viral protein." This patent details methods and compositions for cloning and expressing a Herpes Simplex Virus (HSV) glycoprotein (gD) gene in single-cell host organisms. The patent also describes methods for culturing these novel single-cell organisms to produce the HSV-gene product. The HSV gD-related polypeptide produced through these recombinant DNA techniques may be formulated for use as an immunogen in a vaccine to protect against HSV-1 and HSV-2 infections.

Career Highlights

Throughout his career, John W. Weis has been associated with the American Cyanamid Company, where he has contributed to various research initiatives. His work has been pivotal in advancing the understanding of viral proteins and their applications in medicine.

Collaborations

John has collaborated with esteemed colleagues such as Roger J. Watson and Lynn W. Enquist. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.

Conclusion

John W. Weis is a distinguished inventor whose work in the production of herpes simplex viral proteins has the potential to impact vaccine development significantly. His contributions to the field of virology exemplify the importance of innovation in addressing public health challenges.